Heart Health News

January 26, 2006

Heart Surgery Drug Aprotinin Doubles a Patient's Risk of Kidney Failure

A popular drug given to more than a million people since 1993 to limit blood loss during heart surgery doubles a patient's risk of kidney failure and substantially increases the risk of a heart attack, a major study has found.

The research, being published today in the New England Journal of Medicine with a supportive editorial and commentary, concluded that use of the drug -- Bayer Corp.'s aprotinin -- causes more than 11,000 patients worldwide to need kidney dialysis each year. (Washington Post)

Posted by news editor | Filed under: Heart Bypass Surgery

More News Topics:
Breast Cancer      Alternative Medicine      Infectious Disease       Eating Disorders       Sleep      Orthopedic      Allergies      Neurological Disorders      Senior Health       Mental Health       Autoimmune Disorders       Women's Health
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your health routine or treatment.

Copyright © 2004-2005 HealthDiaries.com. All rights reserved.